Kistamicin A

Kistamicin A has antiviral effect, and its ID50s against influenza virus MDCK cells and herpes simplex virus are respectively 3.6 μg/mL and 44 μg/mL. Kistamicin A also has anti-Gram-positive bacterial effects[1].

Product Specifications

CAS Number

155683-50-4

UNSPSC

12352211

Target

Bacterial; Influenza Virus

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

OC(C=C1)=CC=C1C[C@@H](N)C(N[C@@H]2CC3=CNC4=CC(C5=C(O)C6=CC([C@@](C(N[C@]7([H])C8=CC=C(OC9=C(O)C=CC([C@@H](NC([C@@](CC%10=CC=C(O6)C=C%10)([H])NC7=O)=O)C(O)=O)=C9)C(Cl)=C8)=O)([H])NC([C@@H](C%11=CC(O)=CC(O)=C%11)NC2=O)=O)=C5)=CC=C34)=O

Molecular Formula

C61H51ClN8O15

Molecular Weight

1171.56

References & Citations

[1]Anja Greule, et al. Kistamicin biosynthesis reveals the biosynthetic requirements for production of highly crosslinked glycopeptide antibiotics. Nat Commun. 2019 Jun 13;10 (1) :2613.